Brain Metastases News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Does WBRT still have a role for limited brain metastases? - Healio



Does WBRT still have a role for limited brain metastases? 
Healio
The Choosing Wisely recommendation from the American Society for Radiation Oncology (ASTRO) states to not ?routinely add adjuvant WBRT to stereotactic radiosurgery for limited brain metastases.? This has been interpreted as the demise of WBRT in ...

 


Larger trials needed to confirm benefit of targeted therapies, immunotherapy for brain metastases - Healio



Healio
 
Larger trials needed to confirm benefit of targeted therapies, immunotherapy for brain metastases 
Healio
Brain metastases are a common complication of a variety of cancer types and a major cause of morbidity and mortality. As patients with cancer are living longer, and as detection methods improve, the incidence of brain metastases is increasing. Ten ...

 


Post-Resection Stereotactic Radiosurgery in the Treatment of Brain Metastases - LWW Journals



Post-Resection Stereotactic Radiosurgery in the Treatment of Brain Metastases 
LWW Journals
Historically, whole-brain radiation therapy (WBRT) has been a standard of care therapy for patients who have undergone surgical resection of brain metastases. While WBRT improves local tumor control following surgery, it is associated with several ...

 


Patients With Brain Metastases May Now Have a Better Chance of Inclusion in Clinical Trials - www.oncnursingnews.com/



www.oncnursingnews.com/
 
Patients With Brain Metastases May Now Have a Better Chance of Inclusion in Clinical Trials 
www.oncnursingnews.com/
The guidelines ? issued in Lancet Oncology ? were developed by an expert working group called the Response Assessment in Neuro-Oncology - Brain Metastases (RANO-BM) group. This group included researchers from Dana-Farber Cancer Institute, City of Hope ...

 


Tucatinib Combo Explored in HER2-Positive Breast Cancer - OncLive



OncLive
 
Tucatinib Combo Explored in HER2-Positive Breast Cancer 
OncLive
One of the challenges in the treatment of HER2-positive breast cancer is the frequent development of brain metastases, which can occur in up to 50% of patients. Tucatinib in combination has shown some early signs of activity in the CNS in addition to ...
Seagen swaps ADC hopeful for breast cancer bolt-on in $614M Cascadian buy BioWorld Online

all 2 news articles » 


Viruses Successfully Deliver Immunotherapy Agents to Brain Tumors in UK Study - www.oncnursingnews.com/



www.oncnursingnews.com/
 
Viruses Successfully Deliver Immunotherapy Agents to Brain Tumors in UK Study 
www.oncnursingnews.com/
To treat brain tumors, most studies have administered these viruses using direct intralesional injection because it is believed that intravenous administration does not effectively deliver the virus to the site in the brain. In a window-of-opportunity ...
Metastases ? the real cancer risk Brinkwire (press release)

all 4 news articles » 


Is Selling Stock Like NovoCure Limited (NVCR) After Such Decline Winning Strategy? - BZ Weekly



Press Telegraph
 
Is Selling Stock Like NovoCure Limited (NVCR) After Such Decline Winning Strategy? 
BZ Weekly
The firm markets its proprietary therapy, TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer. It currently has negative earnings. It is also involved in conducting ...
Financial Newsletter - Zacks Zacks
SEC FORM 4 - SEC.gov SEC.gov
SEC FORM 4 - SEC.gov SEC.gov

all 27 news articles » 


Blackwell Sheds Light on Recent Advances in HER2+ Breast Cancer - OncLive



OncLive
 
Blackwell Sheds Light on Recent Advances in HER2+ Breast Cancer 
OncLive
OncLive: What are your thoughts on the data reported with tucatinib in patients with brain metastases? Blackwell: Tucatinib is one of the most exciting agents out there in the investigative space that is trying to improve on current therapies for HER2 ...

and more » 


Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies ... - Cancer Network



Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies ... 
Cancer Network
[8] The limited evidence for immunotherapy to date in the treatment of brain metastases stems from the deliberate exclusion of patients with active brain metastases from many large randomized trials assessing drug efficacy. However, comparable efficacy ...

 


Early-Access Customers Report on NanoString's Sequencing and Digital Spatial Profiling Technologies - GenomeWeb



Early-Access Customers Report on NanoString's Sequencing and Digital Spatial Profiling Technologies 
GenomeWeb
In addition, he's tested the technology on samples from melanoma patients with brain metastases, comparing the brain metastases to non-brain metastases. Metastatic tumors in the brain are the most common cause of death for melanoma patients, with ...